T-PAS |
Nair et al. |
[21] |
Investigation of the clot structure of CPs. |
T-PAS |
Reddoch-Cardenas et al. |
[56] |
Compared CPs stored in PAS versus RPs and CPs in plasma. |
T-PAS and Intersol |
Getz et al. |
[10] |
Reduce aggregate formation in CPs using PAS. |
SSP+ |
Six et al. |
[47] |
Pathogen inactivation (Intercept). |
SSP+ |
Johnson et al. |
[49] |
Pathogen inactivation (Theraflex UV-platelet System). |
SSP+ |
Marini et al. |
[54] |
Plasma replacement and test for the percentage of residual plasma required. |
SSP+ |
Wood et al. |
[60] |
Delayed cold storage. |
PAS-E |
Hegde et al. |
[32] |
NAC supplementation in CPs |
PAS-E |
Johnson et al. |
[57] |
Prolonged platelet cold storage. |
Intersol |
Agey et al. |
[48] |
Pathogen inactivation (Intercept). |
Isoplate |
Reddoch-Cardenas et al. |
[58] |
Preserving mitochondrial function in CPs. |
Isoplate and Intersol |
Reddoch-Cardenas et al. |
[55] |
Compare the CPs storage characteristics in two FDA approved PAS. |
Isoplate and Intersol |
Stolla et al. |
[59] |
PAS in CPs in vivo recoveries using autologous radiolabeled platelet transfusion. |
PAS-IIIM |
Braathen et al. |
[61] |
Delayed cold storage. |